Corporate Responsibility Report

Overview

The report highlights AVITA Medical's growth in wound care, including FDA approval of RECELL GO in May 2024 and the company's broader portfolio ambitions. It reports that more than 3,000 patients were treated with more than 7,000 RECELL devices in calendar 2023. Workforce disclosures include a 48% female employee share, while the company reports zero health and safety incidents for 2023.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: Ends 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services